Cannabis / CBD
When you stroll through the Duquesne campus this spring, you’ll hear a new kind of buzz - not about football scores, but about cannabinoids, labs, and the next wave of cannabis science. Students are swapping study groups for pipettes, and the university’s cannabis research program has become the
Cannabis / CBD
Ever watched a stir-fry turn into a blackened mess and wondered why the oil seemed to quit after just one night? The culprit is often the wrong cooking oil, and the solution is surprisingly simple: pick a high-smoke-point oil that stays stable, costs less per ounce, and lasts longer in
Cannabis / CBD
When Texas lawmakers finally moved cannabis to Schedule III, the headlines focused on patient access. Behind the scenes, a quieter revolution began: a flood of federal dollars, university labs gearing up for a pivot, and a state-wide economic engine humming to life. In 2024, the numbers are crystal clear -
Cannabis / CBD
Imagine walking into your favorite Denver coffee shop, ordering a cold-brew, and watching a tiny QR code pop up on the cup lid promising a precise 10 mg dose of calm. That scenario isn’t sci-fi; it’s the new reality for cafés that have turned the 2023 Farm Bill’
Cannabis / CBD
Imagine a Texas veteran, scarred by combat, finally finding a prescription that eases nightly nightmares without the side-effects of traditional drugs. That scenario moves from wishful thinking to realistic possibility now that Texas has reclassified cannabis from Schedule I to Schedule III. The change cracks open a legal door that
Cannabis / CBD
Imagine walking into a Michigan dispensary, picking up a pre-rolled joint, and never seeing the extra 5% that the state tucks onto the price tag. That invisible levy has been quietly draining retailer profits while inflating the state’s tax receipts. With the 2024 election looming and the industry still
Cannabis / CBD
Why 2026 Is the Year of Proven CBD Oil 2026 finally delivers a trustworthy market for CBD oil because three years of tighter regulations have forced manufacturers to publish full lab reports and adopt uniform potency standards. The Federal Hemp Safety Act of 2024 requires every batch to be tested
Cannabis / CBD
When a Texas veteran walks into a clinic and asks about medical cannabis for PTSD, the answer often lands in a maze of statutes and limited data. In 2024, the state sits at a crossroads: a Schedule III designation offers a legal foothold, but without a coordinated plan the opportunity
Cannabis / CBD
When the Texas Legislature voted to shift marijuana down the schedule ladder this spring, the ripple effect was immediate: a $150 million research pipeline poised to turn speculation into hard data. The move feels like opening a floodgate in a desert - suddenly, the state’s scientists, doctors, and patients
Cannabis / CBD
Picture a scientist who’s spent years waiting for a key to a locked lab door. In 2024, Congress finally turned that key, moving cannabis from Schedule I to Schedule III and opening a hallway of federal dollars, faster trials, and a more attractive investment landscape. The ripple effects are